日本消化器病学会アーカイブシステム

セッション	検索結果は4件です。 IF4a-1 A Comparison of Viral Hepatitis A (HAV) and E (HEV) in the United States and Asia Kenrad E. Nelson（Johns Hopkins UniversityUSA） Acute HEV in the USA decreased 93．70／o from 1990 （14／100000） to 2009 （O．6／100000）． HAV vaccine wasrecom血ended for high risk persons（1996）all chilldren in high incidence areas（1999）and all children at1... 第98回日本消化器病学会総会＞ IF4a-2 Viral Hepatitis A and E in Japan Yoko Tamada（Clinical Research CenterNational Hospital Organization(NHO)Nagasaki Medical CenterJapan） Objective ：To examine recent trends of hepatitis A （AHA） and hepatitis E （AHE） in Japan．Methods ：During 1980 through 2010sentinel surve皿ance was conducted in 31 national hospitals in a prospective co－... 第98回日本消化器病学会総会＞ IF4a-3 Culture Systems for HEV Hiroaki Okamoto（Division of VirologyDepartment of Infection and ImmunityJichi Medical University School of MedicineJapan） Early studies reported the propagation of hepatitis E virus （HEV） in either primary hepatocytes or severalestablishe・d cell linesbut replication was inefficient． Recentlyefficient culture systems have... 第98回日本消化器病学会総会＞ IF4a-4 HEV Vaccine Strategies ： Utility and Prospect James Wai Kuo Shih（National Institute of Diagnostics and Vaccine DevelopmentSchool of Public HealthXiamen UniversityChina） The hepatitis E vaccineHEV239（Hecolin）w皿be commercially available in China in 2012The vaccinehas been shown in a 1arge Phase III clinical trial to be well tolerated by adults and confer 1000／o protect... 第98回日本消化器病学会総会＞

セッション

検索結果は4件です。

IF4a-1 A Comparison of Viral Hepatitis A (HAV) and E (HEV) in the United States and Asia: Kenrad E. Nelson（Johns Hopkins UniversityUSA）
Acute HEV in the USA decreased 93．70／o from 1990 （14／100000） to 2009 （O．6／100000）． HAV vaccine wasrecom血ended for high risk persons（1996）all chilldren in high incidence areas（1999）and all children at1...
第98回日本消化器病学会総会＞
IF4a-2 Viral Hepatitis A and E in Japan: Yoko Tamada（Clinical Research CenterNational Hospital Organization(NHO)Nagasaki Medical CenterJapan）
Objective ：To examine recent trends of hepatitis A （AHA） and hepatitis E （AHE） in Japan．Methods ：During 1980 through 2010sentinel surve皿ance was conducted in 31 national hospitals in a prospective co－...
第98回日本消化器病学会総会＞
IF4a-3 Culture Systems for HEV: Hiroaki Okamoto（Division of VirologyDepartment of Infection and ImmunityJichi Medical University School of MedicineJapan）
Early studies reported the propagation of hepatitis E virus （HEV） in either primary hepatocytes or severalestablishe・d cell linesbut replication was inefficient． Recentlyefficient culture systems have...
第98回日本消化器病学会総会＞
IF4a-4 HEV Vaccine Strategies ： Utility and Prospect: James Wai Kuo Shih（National Institute of Diagnostics and Vaccine DevelopmentSchool of Public HealthXiamen UniversityChina）
The hepatitis E vaccineHEV239（Hecolin）w皿be commercially available in China in 2012The vaccinehas been shown in a 1arge Phase III clinical trial to be well tolerated by adults and confer 1000／o protect...
第98回日本消化器病学会総会＞